{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifyxfc7clx3u2enb6v65kftvoz6d3j6nab4x2h4h7y2atvm4s64nq",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mjh4bntu6ve2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreic6wsfuwvynbzosmtn3zqhdkukehomd6y4nmqykew7orbsrjnp7xq"
    },
    "mimeType": "image/jpeg",
    "size": 261333
  },
  "path": "/news/2026-04-drug-year-survival-pancreatic-cancer.html",
  "publishedAt": "2026-04-14T05:00:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Pancreatic cancer is one of the deadliest cancers and among the hardest to treat, with most patients surviving less than a year after diagnosis. But a new drug developed at Northwestern University may soon help patients live longer.",
  "title": "New drug doubles 1-year survival in pancreatic cancer trial"
}